Bench-to-bedside review: Neonatal sepsis - redox processes in pathogenesis

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Spasojević, Ivan ^a   Obradović, Budimir ^b   Spasić, Snežana ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Medical Centre 'Sveti Luka'   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

BODY TEMPERATURE; BRAIN DISEASE; HEARING IMPAIRMENT; HEART INJURY; HUMAN; LUNG DISEASE; MORTALITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURVIVOR; THERMOGENESIS; VISUAL IMPAIRMENT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MITOCHONDRION; NEWBORN; OXIDATION REDUCTION REACTION; SEPSIS;

HUMANS; HYDROGEN PEROXIDE; INFANT, NEWBORN; INTERLEUKIN-6; INTERLEUKIN-8; MITOCHONDRIA; NF-KAPPA B; OXIDATION-REDUCTION; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860791562     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11183     Document Type: Review

References (102)

1. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: A review of evidence from community-based studies. Pediatr Infect Dis J 2009, 28:S3-S9.
2. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: When? Where? Why?. Lancet 2005, 365:891-900.
3. Andrades M, Morina A, Spasić S, Spasojević I. Bench-to-bedside review: Sepsis - from the redox point of view. Crit Care 2011, 15:230.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001, 29:1303-1311.
5. Baltimore RS. Neonatal sepsis: epidemiology and management. Paediatr Drugs 2003, 5:723-740.
6. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005, 116:595-602.
7. Wu JH, Chen CY, Tsao PN, Hsieh WS, Chou HC. Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan. Pediatr Neonatol 2009, 50:88-95.
8. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36:222-231. 2826633, 20069275.
9. Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117:84-92.
10. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
11. Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med 2008, 9:186-191.
12. Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Rommes JH, Bakker J. The impact of severe sepsis on health-related quality of life: a long-term follow-up study. Anesth Analg 2008, 107:1957-1964.
13. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest 2006, 130:869-878.
14. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693.
15. Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002, 40:275-279.
16. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001, 29:1303-1311.
17. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-335.
18. Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol 2006, 26:18-22.
19. Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr 2010, 10:39. 2889942, 20525358.
20. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact. Pediatrics 2010, 125:1031-1041. 2894560, 20421258.
21. Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis 2008, 8:19-31.
22. Tarnow-Mordi W, Isaacs D, Dutta S. Adjunctive immunologic interventions in neonatal sepsis. Clin Perinatol 2010, 37:481-499.
23. Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 2010, 7:e1000213. 2834705, 20231868.
24. Melvan JN, Bagby GJ, Welsh DA, Nelson S, Zhang P. Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol 2010, 29:315-348. 3103186, 20521927.
25. Cherian S, Jameson S, Rajarajeswari C, Helena V, Latha L, Rekha A, Nagamma T, Raju S, Kini PG, Rao A. Oxidative stress in sepsis in children. Indian J Med Res 2007, 125:143-148.
26. Batra S, Kumar R, Kapoor AK, Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 2000, 20:27-33.
27. Kakita H, Hussein MH, Daoud GA, Kato T, Murai H, Sugiura T, Mizuno K, Yamada Y, Ito T, Fukuda S, Kato I, Suzuki S, Togari H. Total hydroperoxide and biological antioxidant potentials in a neonatal sepsis model. Pediatr Res 2006, 60:675-679.
28. Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003, 3:CD003665.
29. Volante E, Moretti S, Pisani F, Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med 2004, 16:13-16.
30. Ng PC, Lam HS. Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol 2010, 37:599-610.
31. Küster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, Geiger R, Lipowsky G, Simbruner G. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998, 352:1271-1277.
32. Nese Citak Kurt N, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1β, IL-6, IL-8, and TNF-α levels in early diagnosis and management of neonatal sepsis. Mediators Infl amm 2007, 2007:31397.
33. Krueger M, Nauck MS, Sang S, Hentschel R, Wieland H, Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 2001, 80:118-123.
34. Orlikowsky TW, Neunhoeffer F, Goelz R, Eichner M, Henkel C, Zwirner M, Poets CF. Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr Res 2004, 56:804-809.
35. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736.
36. Arnalich F, Garcia-Palomero E, López J, Jiménez M, Madero R, Renart J, Vázquez JJ, Montiel C. Predictive value of nuclear factor kB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000, 68:1942-1945. 97370, 10722586.
37. Böhrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Männel D, Böttiger BW, Stern DM, Waldherr R, Saeger HD, Ziegler R, Bierhaus A, Martin E, Nawroth PP. Role of NF-kB in the mortality of sepsis. J Clin Invest 1997, 100:972-985. 508272, 9276714.
38. Koch L, Fritzsching B, Frommhold D, Poeschl J. Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK. Neonatology 2011, 99:140-145.
39. Cao W, Li XQ, Zhang XN, Hou Y, Zeng AG, Xie YH, Wang SW. Madecassoside suppresses LPS-induced TNF-alpha production in cardiomyocytes through inhibition of ERK, p38, and NF-kappaB activity. Int Immunopharmacol 2010, 10:723-729.
40. Peng T, Lu X, Feng Q. NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J 2005, 19:293-295.
41. Hickson-Bick DL, Jones C, Buja LM. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. Shock 2006, 25:546-552.
42. Jung HS, Yoon BH, Jun JK, Kim M, Kim YA, Kim CJ. Differential activation of mitogen activated protein kinases and nuclear factor-kappaB in lipopolysaccharide-treated term and preterm amnion cells. Virchows Arch 2005, 447:45-52.
43. Kenzel S, Mancuso G, Malley R, Teti G, Golenbock DT, Henneke P. c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis. J Immunol 2006, 176:3181-3188.
44. Pan F, Shi Y, Li HQ, Zhao JN, Tang SF, Yao ZK. Activation of nuclear factor kappa B in newborn rats sepsis. Zhonghua Er Ke Za Zhi 2003, 41:582-585.
45. Manna SK, Ramesh GT. Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway. J Biol Chem 2005, 280:7010-7021. 2740382, 15591054.
46. Manna SK, Babajan B, Raghavendra PB, Raviprakash N, Sureshkumar C. Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1. J Biol Chem 2010, 285:11617-11627. 2857039, 20133937.
47. Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV. IL-6 induces NF-kappa B activation in the intestinal epithelia. J Immunol 2003, 171:3194-3201.
48. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011, 1813:878-888.
49. Tamariz L, Hare JM. Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. Eur Heart J 2010, 31:768-770.
50. Mittal R, Gonzalez-Gomez I, Goth KA, Prasadarao NV. Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis. Am J Pathol 2010, 176:1292-1305. 2832150, 20093483.
51. Wang H, Wu YB, Du XH. Effect of dexamethasone on nitric oxide synthase and Caspase-3 gene expressions in endotoxemia in neonate rat brain. Biomed Environ Sci 2005, 18:181-186.
52. Orellana RA, Suryawan A, Kimball SR, Wu G, Nguyen HV, Jefferson LS, Davis TA. Insulin signaling in skeletal muscle and liver of neonatal pigs during endotoxemia. Pediatr Res 2008, 64:505-510. 2774270, 18596577.
53. Glibetic M, Samlalsingh-Parker J, Raykova V, Ofenstein J, Aranda JV. Group B Streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol 2001, 25:65-69.
54. Nögel SC, Chada M, Schmidt AM, Bosselmann S, Kandler M, Schweer H, Watzer B, Schneider H, Gessner A, Rascher W. Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis. Prostaglandins Other Lipid Mediat 2009, 90:7-12.
55. Natarajan G, Glibetic M, Raykova V, Ofenstein JP, Thomas RL, Aranda JV. Nitric oxide and prostaglandin response to group B streptococcal infection in the lung. Ann Clin Lab Sci 2007, 37:170-176.
56. Kaftan HA, Clark PL, Norberg M, Garg U, Thibeault DW, Truog WE. Endogenous production of nitric oxide in endotoxemic piglets. Biol Neonate 2003, 83:42-48.
57. Hovsepian E, Penas F, Goren NB. 15-deoxy-Δ12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor γ-dependent and -independent mechanisms in cardiac cells. Shock 2010, 34:60-67.
58. Ergenekon E, Gücüyener K, Erbaş D, Koç E, Ozturk G, Atalay Y. Urinary nitric oxide in newborns with infections. Biol Neonate 2000, 78:92-97.
59. Figueras-Aloy J, Gómez L, Rodríguez-Miguélez JM, Jordán Y, Salvia MD, Jiménez W, Carbonell-Estrany X. Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal sepsis. Acta Paediatr 2003, 92:582-587.
60. Marom D, Yuhas Y, Sirota L, Livni G, Ashkenazi S. Nitric oxide levels in preterm and term infants and in premature infants with bacteremia. Biol Neonate 2004, 86:160-164.
61. Davies NA, Cooper CE, Stidwell R, Singer M. Inhibition of mitochondrial respiration during early stage sepsis. Adv Exp Med Biol 2003, 530:725-736.
62. Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 2008, 28:13957-13966. 2752712, 19091984.
63. Miyoshi T, Yamashita K, Arai T, Yamamoto K, Mizugishi K, Uchiyama T. The role of endothelial interleukin-8/NADPH oxidase 1 axis in sepsis. Immunology 2010, 131:331-339. 2996553, 20518825.
64. Oddis CV, Finkel MS. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem Biophys Res Commun 1995, 213:1002-1009.
65. Romeo C, Eaton S, Spitz L, Pierro A. Nitric oxide inhibits neonatal hepatocyte oxidative metabolism. J Pediatr Surg 2000, 35:44-48.
66. Fukumoto K, Pierro A, Spitz L, Eaton S. Differential effects of neonatal endotoxemia on heart and kidney carnitine palmitoyl transferase I. J Pediatr Surg 2002, 37:723-726.
67. Markley MA, Pierro A, Eaton S. Hepatocyte mitochondrial metabolism is inhibited in neonatal rat endotoxaemia: effects of glutamine. Clin Sci (Lond) 2002, 102:337-344.
68. Garrett-Cox RG, Pierro A, Spitz L, Eaton S. Body temperature and heat production in suckling rat endotoxaemia: beneficial effects of glutamine. J Pediatr Surg 2003, 38:37-44.
69. Vejchapipat P, Eaton S, Fukumoto K, Parkes HG, Spitz L, Pierro A. Hepatic glutamine metabolism during endotoxemia in neonatal rats. Nutrition 2002, 18:293-297.
70. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004, 351:2112-2114.
71. Arstall MA, Sawyer DB, Fukazawa R, Kelly RA. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 1999, 85:829-840.
72. Barnes PJ. Nuclear factor-κB. Int J Biochem Cell Biol 1997, 29:867-870.
73. Sheldon RA, Christen S, Ferriero DM. Genetic and pharmacologic manipulation of oxidative stress after neonatal hypoxia-ischemia. Int J Dev Neurosci 2008, 26:87-92. 2703481, 17935927.
74. Darlow BA, Austin N. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev 2003, 4:CD003312.
75. Martin M, Macias M, Escames G, Leon J, Acuna-Castroviejo D. Melatonin but not vitamins C and E maintains glutathione homeostasis in tert-butyl hydroperoxide induced mitochondrial oxidative stress. FASEB J 2000, 14:1677-1679.
76. Sanodze N, Uberi N, Uberi E, Kulumbegov B. Parameters of oxidative metabolism in neonates suffering from sepsis and anemia. Georgian Med News 2006, 140:65-67.
77. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006, 19:290-297.
78. Wheater M, Rennie JM. Perinatal infection is an important risk factor for cerebral palsy in very-lowbirthweight infants. Dev Med Child Neurol 2000, 42:364-367.
79. O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002, 8:135-145.
80. Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 2004, 4:729-741.
81. Kroemer G, Reed JC. Mitochondrial control of cell death. Nature Med 2000, 6:513-519.
82. Stoka V, Turk V, Bredesen DE. Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing. FEBS Lett 2006, 580:3739-3745. 1847410, 16777102.
83. Madden SD, Donovan M, Cotter TG. Key apoptosis regulating proteins are down-regulated during postnatal tissue development. Int J Dev Biol 2007, 51:415-424.
84. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002, 22:455-463.
85. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 2003, 23:3308-3315.
86. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001, 50:553-562.
87. Silveira RC, Procianoy RS. High plasma cytokine levels, white matter injury and neurodevelopment of high risk preterm infants: assessment at two years. Early Hum Dev 2011, 87:433-437.
88. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992, 70:31-46.
89. Yi M, Masood A, Ziino A, Johnson BH, Belcastro R, Li J, Shek S, Kantores C, Jankov RP, Tanswell AK. Inhibition of apoptosis by 60% oxygen: a novel pathway contributing to lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2011, 300:L319-L329.
90. Lukkarinen HP, Laine J, Kääpä PO. Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. Pediatr Res 2003, 53:254-259.
91. Hargitai B, Szabó V, Hajdú J, Harmath A, Pataki M, Farid P, Papp Z, Szende B. Apoptosis in various organs of preterm infants: histopathologic study of lung, kidney, liver, and brain of ventilated infants. Pediatr Res 2001, 50:110-114.
92. Konorev EA, Vanamala S, Kalyanaraman B. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med 2008, 45:1723-1728. 3039518, 18926904.
93. Clifford CB, Slauson DO, Neilsen NR, Suyemoto MM, Zwahlen RD, Schlafer DH. Ontogeny of inflammatory cell responsiveness: superoxide anion generation by phorbol ester-stimulated fetal, neonatal, and adult bovine neutrophils. Inflammation 1989, 13:221-231.
94. Komatsu H, Tsukimori K, Hata K, Satoh S, Nakano H. The characterization of superoxide production of human neonatal neutrophil. Early Hum Dev 2001, 65:11-19.
95. Safronova VG, Matveeva NK, Mal'tseva VN, Bondar' OE, Van'ko LV, Sukhikh GT. Evaluation of the Role of FMLF chemotaxic peptide receptors in umbilical cord blood granulocytes from newborns at risk of infectious inflammatory diseases. Bull Exp Biol Med 2008, 145:452-456.
96. Delacourt C, d'Ortho MP, Macquin-Mavier I, Pezet S, Housset B, Lafuma C, Harf A. Oxidant-antioxidant balance in alveolar macrophages from newborn rats. Eur Respir J 1996, 9:2517-2524.
97. Maródi L, Káposzta R, Campbell DE, Polin RA, Csongor J, Johnston RB. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol 1994, 153:5643-5649.
98. Mohamed MA, Cunningham-Rundles S, Dean CR, Hammad TA, Nesin M. Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 2007, 39:171-177.
99. Kurt-Jones EA, Belko J, Yu C, Newburger PE, Wang J, Chan M, Knipe DM, Finberg RW. The role of Toll-like receptors in herpes simplex infection in neonates. J Infect Dis 2005, 191:746-748.
100. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002, 70:6688-6696. 133091, 12438343.
101. Peters AMJ, Bertram P, Gahr M, Speer CP. Reduced secretion of interleukin-1 and tumor necrosis factor-α by neonatal monocytes. Biol Neonate 1993, 63:157-162.
102. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res 2006, 60:205-209.